Published in Gut on February 01, 2001
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med (1985) 11.68
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem (1997) 3.52
Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem (1992) 2.03
Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol (1990) 1.94
S-nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. Am J Physiol (1995) 1.40
Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun (1996) 1.21
Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol (1992) 1.16
Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur J Pharmacol (1992) 1.11
Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol (1993) 1.09
Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation (1993) 1.09
Mechanisms of ischemic preconditioning. Shock (1997) 1.07
Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. Antagonism with the induction elicited by lipopolysaccharide. J Biol Chem (1992) 1.00
Fructose-1,6-bisphosphate stabilizes brain intracellular calcium during hypoxia in rats. Stroke (1992) 0.96
L-NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs. Br J Pharmacol (1994) 0.92
Decreased ileal muscle contractility and increased NOS II expression induced by lipopolysaccharide. Am J Physiol (1996) 0.92
Nitric oxide modulates water and electrolyte transport in the ileum. Ann Surg (1994) 0.92
Metabolism of exogenously applied fructose 1,6-bisphosphate in hypoxic vascular smooth muscle. Am J Physiol (1994) 0.89
Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ Shock (1994) 0.89
Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6-diphosphate. Stroke (1990) 0.87
Attenuation of ischemic renal injury with fructose 1,6-diphosphate. J Surg Res (1989) 0.86
Glucose-induced intestinal hyperemia is mediated by nitric oxide. J Surg Res (1997) 0.85
Modification of glyceraldehyde-3-phosphate dehydrogenase in response to nitric oxide in intestinal preconditioning. Transplantation (1999) 0.83
Fructose 1-6 diphosphate prevents intestinal ischemic reperfusion injury and death in rats. Gastroenterology (1990) 0.82
The effects of N(G)-nitro-L-arginine-methyl ester on neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits. Anesth Analg (1999) 0.81
Fructose-1,6-bisphosphate as a metabolic substrate in hog ileum smooth muscle during hypoxia. Mol Cell Biochem (1996) 0.81
Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning. J Surg Res (1997) 0.80
Fructose-1,6-diphosphate or adenosine attenuate leukocyte adherence in postischemic skeletal muscle. Am J Physiol (1995) 0.80
Evaluation of a preservation solution containing fructose-1,6-diphosphate and mannitol using the isolated perfused rat kidney. Comparison with Euro-Collins and University of Wisconsin solutions. Nephrol Dial Transplant (1995) 0.79
Exogenous fructose 1,6-bisphosphate reduces K+ permeability in isolated rat hepatocytes. Am J Physiol (1997) 0.78
Ischemia and reperfusion: effect of fructose-1,6-bisphosphate. Free Radic Res Commun (1992) 0.77
Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology (1997) 1.59
Cyclooxygenase and lipoxygenase metabolism in sodium taurocholate induced acute hemorrhagic pancreatitis in rats. Prostaglandins (1993) 1.46
Riboflavin 3'- and 5'-sulfate, two novel flavins accumulating in the roots of iron-deficient sugar beet (Beta vulgaris). J Biol Chem (1993) 1.44
Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology (2001) 1.43
Effects of adenosine on ischaemia-reperfusion injury associated with rat pancreas transplantation. Br J Surg (2001) 1.42
Serotonergic status in human blood. Life Sci (1988) 1.38
Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. J Pathol (2008) 1.33
Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis (2010) 1.31
Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary-phase cultures. Microbiology (2002) 1.24
Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun (1996) 1.21
Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun (1996) 1.19
Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med (1993) 1.18
Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med (1993) 1.16
Activation of alveolar macrophages in lung injury associated with experimental acute pancreatitis is mediated by the liver. Ann Surg (1999) 1.16
Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol (2000) 1.15
Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology (2001) 1.15
Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res (1999) 1.14
Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology (1999) 1.12
The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology (1999) 1.11
Effect of abscisic Acid on the linoleic Acid metabolism in developing maize embryos. Plant Physiol (1991) 1.04
Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation (2002) 1.04
Role of P-selectin and ICAM-1 in pancreatitis-induced lung inflammation in rats: significance of oxidative stress. Ann Surg (1999) 1.02
The response of the hepatocyte to ischemia. Liver Int (2007) 1.01
Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis (1992) 0.98
Free radical enhancement promotes leucocyte recruitment through a PAF and LTB4 dependent mechanism. Free Radic Biol Med (1997) 0.98
Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg (2001) 0.97
Leukotriene generation and neutrophil infiltration after experimental acute pancreatitis. Inflammation (1998) 0.97
Actin cytoskeleton derangement induces apoptosis in renal ischemia/reperfusion. Apoptosis (2006) 0.97
Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology (1998) 0.96
Hepatic involvement in pancreatitis-induced lung damage. Am J Physiol (1996) 0.94
Free radicals generated by xanthine oxidase mediate pancreatitis-associated organ failure. Dig Dis Sci (1998) 0.94
IGL-1 solution reduces endoplasmic reticulum stress and apoptosis in rat liver transplantation. Cell Death Dis (2012) 0.93
Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix. Am J Transplant (2010) 0.93
Cyclooxygenase and lipoxygenase arachidonic acid metabolism by monocytes from human immune deficiency virus-infected drug users. J Chromatogr (1991) 0.91
Mitochondrial NOS upregulation during renal I/R causes apoptosis in a peroxynitrite-dependent manner. Kidney Int (2006) 0.91
P-selectin expression and Kupffer cell activation in rat acute pancreatitis. Dig Dis Sci (2000) 0.91
Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant (2007) 0.90
Liver ischemic preconditioning: a new strategy for the prevention of ischemia-reperfusion injury. Transplant Proc (2003) 0.89
P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine. Thorax (2002) 0.89
Modification of oxidative stress in response to intestinal preconditioning. Transplantation (2000) 0.89
Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic Res (2000) 0.88
Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation. Transplantation (2003) 0.87
How ischaemic preconditioning protects small liver grafts. J Pathol (2006) 0.87
Heparin mobilizes xanthine oxidase and induces lung inflammation in acute pancreatitis. Crit Care Med (2003) 0.87
The assessment of biomarkers to detect nephrotoxicity using an integrated database. Environ Res (1997) 0.85
Pancreatic nitric oxide and oxygen free radicals in the early stages of streptozotocin-induced diabetes mellitus in the rat. Braz J Med Biol Res (2000) 0.84
H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis. Free Radic Biol Med (2000) 0.84
Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures. Biol Psychiatry (1989) 0.84
Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation (2000) 0.84
Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biol Psychiatry (1987) 0.84
Efficacy of polyethylene glycols in University of Wisconsin preservation solutions: a study of isolated perfused rat liver. Transplant Proc (2005) 0.83
Differential activity of nitric oxide synthase in human nasal mucosa and polyps. Eur Respir J (1996) 0.83
Quantitative peptide bioanalysis using column-switching nano liquid chromatography/mass spectrometry. J Mass Spectrom (1998) 0.83
Xanthine oxidase activation in cerulein- and taurocholate-induced acute pancreatitis in rats. Arch Int Physiol Biochim Biophys (1995) 0.83
Tepoxalin inhibits inflammation and microvascular dysfunction induced by abdominal irradiation in rats. Aliment Pharmacol Ther (2000) 0.83
Modification of glyceraldehyde-3-phosphate dehydrogenase in response to nitric oxide in intestinal preconditioning. Transplantation (1999) 0.83
Convulsant effect of lindane and regional brain concentration of GABA and dopamine. Toxicology (1988) 0.83
Protection of reduced-size liver for transplantation. Am J Transplant (2004) 0.83
Prostanoids and free radicals in Cl4C-induced hepatotoxicity in rats: effect of astilbin. Prostaglandins Leukot Essent Fatty Acids (1997) 0.83
Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Transplantation (2001) 0.82
Prostaglandin D2, F2 alpha, E2, and E1 in early phase of experimental acute necrohemorrhagic pancreatitis in rats. Pancreas (1994) 0.82
Ischemic preconditioning: tolerance to hepatic ischemia-reperfusion injury. Histol Histopathol (2004) 0.82